1 Min Read
* APPROVED INVESTMENT OF RMB355 MILLION TO SET UP UNIT & TO BUILD ACTIVE PHARMACEUTICAL INGREDIENTS BASE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.